In the case of a negative sentinel node biopsy, what is the recommended clinical follow-up?

• A. Immediate chemotherapy
• B. No further lymph node surgery
• C. Annual imaging tests
• D. Routine blood tests for cancer markers

Answer: (B)

When a sentinel node biopsy returns negative results, it indicates that there is no cancer spread to the sentinel lymph nodes, which are the first nodes to which cancer is likely to spread from the primary tumor. In this context, the recommendation of no further lymph node surgery is based on the understanding that if the sentinel nodes are clear of cancer, the likelihood of additional lymph nodes being affected is significantly reduced.

This approach avoids unnecessary surgical interventions, which can lead to complications and impacts on the patient’s quality of life without providing any additional benefit in terms of cancer control or survival. Furthermore, monitoring can instead focus on other clinical aspects, as the negative sentinel node biopsy offers reassurance regarding lymphatic spread.

Other options, such as immediate chemotherapy or annual imaging tests, are not indicated in this scenario since the negative result decreases the urgency for aggressive treatment or extensive follow-up that might not yield additional useful information. Routine blood tests for cancer markers are also not standard practice based solely on the sentinel node biopsy outcome. The emphasis is on minimizing unnecessary procedures while still closely monitoring the patient's overall status.